Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q498R1

Entry ID Method Resolution Chain Position Source
AF-Q498R1-F1 Predicted AlphaFoldDB

No variants for Q498R1

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q498R1

No associated diseases with Q498R1

16 regional properties for Q498R1

Type Name Position InterPro Accession
domain Flavodoxin-like 5 - 18 IPR001094-1
domain Flavodoxin-like 54 - 65 IPR001094-2
domain Flavodoxin-like 88 - 98 IPR001094-3
domain Flavodoxin-like 112 - 131 IPR001094-4
domain Oxidoreductase FAD/NAD(P)-binding 543 - 663 IPR001433
domain Flavoprotein pyridine nucleotide cytochrome reductase 308 - 318 IPR001709-1
domain Flavoprotein pyridine nucleotide cytochrome reductase 452 - 459 IPR001709-2
domain Flavoprotein pyridine nucleotide cytochrome reductase 488 - 497 IPR001709-3
domain Flavoprotein pyridine nucleotide cytochrome reductase 542 - 561 IPR001709-4
domain Flavoprotein pyridine nucleotide cytochrome reductase 573 - 582 IPR001709-5
domain Flavoprotein pyridine nucleotide cytochrome reductase 586 - 597 IPR001709-6
domain Flavoprotein pyridine nucleotide cytochrome reductase 624 - 640 IPR001709-7
domain Flavoprotein pyridine nucleotide cytochrome reductase 648 - 656 IPR001709-8
domain Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding 274 - 493 IPR003097
domain Flavodoxin/nitric oxide synthase 4 - 147 IPR008254
domain FAD-binding domain, ferredoxin reductase-type 272 - 534 IPR017927

Functions

Description
EC Number 1.16.1.8 With NAD(+) or NADP(+) as acceptor
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
intermediate filament cytoskeleton Cytoskeletal structure made from intermediate filaments, typically organized in the cytosol as an extended system that stretches from the nuclear envelope to the plasma membrane. Some intermediate filaments run parallel to the cell surface, while others traverse the cytosol; together they form an internal framework that helps support the shape and resilience of the cell.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.

8 GO annotations of molecular function

Name Definition
[methionine synthase] reductase activity Catalysis of the reaction: -cob(II)alamin + NADPH + H+ + S-adenosyl methionine = -methylcob(I)alamin + S-adenosylhomocysteine + NADP+.
FAD binding Binding to the oxidized form, FAD, of flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
flavin adenine dinucleotide binding Binding to FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
FMN binding Binding to flavin mono nucleotide. Flavin mono nucleotide (FMN) is the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.
NADPH binding Binding to the reduced form, NADPH, of nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions.
NADPH-hemoprotein reductase activity Catalysis of the reaction: NADPH + H+ + n oxidized hemoprotein = NADP+ + n reduced hemoprotein.
oxidoreductase activity Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor Catalysis of an oxidation-reduction in which the metal ion is reduced and NAD+ or NADP+ acts as an electron acceptor.

9 GO annotations of biological process

Name Definition
cobalamin metabolic process The chemical reactions and pathways involving cobalamin (vitamin B12), a water-soluble vitamin characterized by possession of a corrin nucleus containing a cobalt atom.
DNA methylation The covalent transfer of a methyl group to either N-6 of adenine or C-5 or N-4 of cytosine.
folic acid metabolic process The chemical reactions and pathways involving folic acid, pteroylglutamic acid. Folic acid is widely distributed as a member of the vitamin B complex and is essential for the synthesis of purine and pyrimidines.
homocysteine catabolic process The chemical reactions and pathways resulting in the breakdown of homocysteine, the amino acid alpha-amino-gamma-mercaptobutanoic acid.
homocysteine metabolic process The chemical reactions and pathways involving homocysteine, the amino acid alpha-amino-gamma-mercaptobutanoic acid. Homocysteine is an important intermediate in the metabolic reactions of its S-methyl derivative, methionine.
methionine biosynthetic process The chemical reactions and pathways resulting in the formation of methionine (2-amino-4-(methylthio)butanoic acid), a sulfur-containing, essential amino acid found in peptide linkage in proteins.
negative regulation of cystathionine beta-synthase activity Any process that stops, prevents or reduces the frequency, rate or extent of cystathionine beta-synthase activity.
regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process.
S-adenosylmethionine cycle A cyclic series of interconversions involving S-adenosylmethionine, S-adenosyl-L-homocysteine, L-cysteine, and L-methionine. Couples utilization of the methyl group of SAM with recycling of the homocysteinyl group and regeneration of methionine.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P29473 NOS3 Nitric oxide synthase, endothelial Bos taurus (Bovine) EV
Q1JPJ0 NDOR1 NADPH-dependent diflavin oxidoreductase 1 Bos taurus (Bovine) PR
P29474 NOS3 Nitric oxide synthase, endothelial Homo sapiens (Human) SS
P29475 NOS1 Nitric oxide synthase, brain Homo sapiens (Human) SS
Q9UHB4 NDOR1 NADPH-dependent diflavin oxidoreductase 1 Homo sapiens (Human) PR
Q9UBK8 MTRR Methionine synthase reductase Homo sapiens (Human) PR
P70313 Nos3 Nitric oxide synthase 3 Mus musculus (Mouse) SS
A2AI05 Ndor1 NADPH-dependent diflavin oxidoreductase 1 Mus musculus (Mouse) PR
Q8C1A3 Mtrr Methionine synthase reductase Mus musculus (Mouse) PR
Q28969 NOS3 Nitric oxide synthase 3 Sus scrofa (Pig) SS
Q62600 Nos3 Nitric oxide synthase 3 Rattus norvegicus (Rat) SS
P29476 Nos1 Nitric oxide synthase, brain Rattus norvegicus (Rat) SS
Q9FKW6 LFNR1 Ferredoxin--NADP reductase, leaf isozyme 1, chloroplastic Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MRRFLLLYAT QRGQAKAIAE EISEQALSHG FSADLHCVSE SEKYDLKTET GPLVMVVSTT
70 80 90 100 110 120
GTGDPPDTAR KFVKEIHNKT LPTDFFAHLW YGLLGLGDSE YTYFCNGGKV IDKRLQELGA
130 140 150 160 170 180
QHFYDTGHAD DCVGLELVVE PWIDGLWPAL TKHFKSLGGQ EDMSDSDTLA QASDAPLSMA
190 200 210 220 230 240
MKPELLHIQS QVELLSLEDV GKRDSELQEQ NETNKNQPSR IEDFDSSLVN SVPPLSQSSL
250 260 270 280 290 300
SIPAVSPEYL EVYLQESLGQ DENQASVPPS VDPIFQVPIS KAVELTTNDA IKTTLLLELD
310 320 330 340 350 360
ISKVEFSHQP GDSFNVICPN SGSEVEDLLQ RLQLADKQAH RVILKIKMDT KKKGASLPQH
370 380 390 400 410 420
VPEGSSLQFI FTWCLEIRAV PKKAFLRALS DYTSDATEKR RLQELCSKQG AADYNRFIRD
430 440 450 460 470 480
ASVCLLDLLL TFPSCQPPLN LLLEHLPKLQ PRPYSCASSS LLHPDKLHFV FNIVELPSNT
490 500 510 520 530 540
TAASLRKGVC TGWLATLVAP FLQPNTEVLT ADHSDALAPE ILISPRATNS FHLPDDLSAP
550 560 570 580 590 600
IIMVGPGTGV APFVGFLQHR EKLQEQHPDG NFGAMWLFFG CRHKDRDYLF REELRHFLKT
610 620 630 640 650 660
GVLTHLKVSF SRDAAPEEEE EAPAKYVQDN LQHHSQQVAR TLLQENGYIY VCGDAKNMAK
670 680 690
DVHDALVEII SKEAGVDKLE AMKTLATLKQ EKRYLQDIWS